Workflow
首钢朗泽拟全球发售2015.98万股H股 7月9日上市
Zhi Tong Cai Jing·2025-06-29 23:31

Group 1 - The company, Shougang Longze, plans to conduct an IPO from June 30 to July 4, 2025, offering 20.1598 million H-shares, with 10% allocated for Hong Kong and 90% for international sales, at a price not exceeding HKD 18.88 per share and not lower than HKD 14.50 per share [1] - The company specializes in the Carbon Capture, Utilization, and Storage (CCUS) industry, focusing on producing low-carbon products such as ethanol and microbial protein through carbon capture and utilization technology [1] - Since its establishment in 2011, the company has made significant breakthroughs in applying its proprietary synthetic biology technology for industrial production, including the world's first industrial facility that uses carbon-containing industrial waste gas from steel and ferroalloy plants for fermentation to produce ethanol and microbial protein [1] Group 2 - The company's revenue grew rapidly, increasing by 52.1% from RMB 389.5 million in 2022 to RMB 593 million in 2023, but then decreased by 4.9% to RMB 564 million in 2024 [2] - The company reported losses of RMB 23.9 million, RMB 110 million, and RMB 246 million for the years ending December 31, 2022, 2023, and 2024, respectively [2] - The company's EBITDA (non-IFRS measure) for the years ending December 31, 2022, 2023, and 2024 were RMB 33.1 million, RMB 14.2 million, and -RMB 82.5 million, respectively [2] Group 3 - The company intends to use the net proceeds of HKD 284 million from the IPO for various purposes, including approximately 37.9% for developing SAF production facilities in Baotou, Inner Mongolia, and 21.2% for the second phase of production facilities in Hebei [3] - About 11.4% of the proceeds will be allocated for R&D of strains, production equipment, and smart production management systems to enhance production efficiency, while 14.1% will be used for technological upgrades of four production facilities [3] - The remaining proceeds will be used for new product development (5.3%) and general corporate purposes and working capital needs (10.0%) [3]